Skip to main content
logo
Jin Medical International Ltd. (ZJYL)
NASDAQ: ZJYL · Real-Time Price · USD
2.920
+0.770 (35.81%)
At close: Aug 10, 2026, 4:00 PM EDT
3.070
+0.150 (5.14%)
After-hours: Aug 10, 2026, 4:47 PM EDT

Jin Medical International Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
1.161.383.422.882.712.63
Depreciation & Amortization
0.240.240.240.230.360.35
Other Adjustments
-0.290.180.050.2-0.06-0.1
Change in Receivables
0.32.27-3.91-0.380.333.08
Changes in Inventories
-1.040.170.081.56-0.50.46
Changes in Accounts Payable
-0.60.29-0.5-0.65-0.81-0.37
Changes in Accrued Expenses
0.160.250.1-0.07-0.280.03
Changes in Income Taxes Payable
-0.3-0.790.820.030.16-0.1
Changes in Unearned Revenue
0.14-0.17-0.060.02-0.760.65
Changes in Other Operating Activities
-0.43-0.92-1.45-0.720.43-0.79
Operating Cash Flow
-0.592.9-1.213.111.585.84
Operating Cash Flow Growth
---96.53%-72.95%133.44%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Capital Expenditures
-6.37-6.63-0.14-0.11-0.04-0.04
Sale of Property, Plant & Equipment
-000.01--
Purchases of Intangible Assets
---0.98---
Purchases of Investments
-6.99-9.7-21.05-12.05-5.65-4.96
Proceeds from Sale of Investments
6.976.0412.664.435.24.15
Cash Acquisitions
--0.5----
Other Investing Activities
----0.36-0.22
Investing Cash Flow
-6.38-10.79-9.51-7.73-0.12-1.07

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Short-Term Debt Issued
23.219.0212.435.67-0.77
Short-Term Debt Repaid
-21.84-11.43-5.56-1.42--3.53
Net Short-Term Debt Issued (Repaid)
1.367.596.874.25--2.77
Issuance of Common Stock
--0.317.12--
Net Common Stock Issued (Repurchased)
--0.317.12--
Other Financing Activities
0.46-0.244.48-4.470.12-0.1
Financing Cash Flow
4.547.3511.656.910.12-2.87

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Foreign Exchange Rate Adjustments
0.38-0.140.27-0.15-0.460.1
Net Cash Flow
-2.05-0.671.212.141.122.01

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Free Cash Flow
-6.96-3.73-1.352.991.545.8
Free Cash Flow Growth
---94.25%-73.44%145.69%
FCF Margin
-35.28%-18.01%-5.75%15.10%8.03%27.93%
Free Cash Flow Per Share
-0.89-0.48-0.170.410.230.86
Levered Free Cash Flow
-5.671.229.627.421.260.05
Unlevered Free Cash Flow
-7.74-6.883.383.460.662.59
SEC Filings: 10-K · 10-Q